New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Medpace Holdings, Inc.
MEDP
Shape
US Flag

NASDAQ

14B

Medical - Diagnostics & Research

Next Earning date - 20 Oct 2025

14B

Medical - Diagnostics & Research

Next Earning date - 20 Oct 2025

501.94USD

Shape4.11 ( 0.83%)
moonAfter-hours 502.40$arrow-right-up0.46 (0.09%)
Market Closed (as of Sep 18, 20:00 EDT)
favorite-chart

Relative Strenght

89
favorite-chart

Volume Buzz

-61%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

1%

Quote Panel

Shape
Updated September 18, 2025
1W 2.33 % 1M 8.64 % 3M 62.30 % 1Y 36.00 %

Key Metrics

Shape
  • Market Cap

    14.10B


  • Shares Outstanding

    28.09M


  • Share in Float

    22.73M


  • Dividende

    0


  • Earning Date

    20 Oct 2025


  • Price Target

    501.94


  • Average Volume

    492614


  • Beta

    1.445


  • Range

    250.05-506.55


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.medpace.com


  • Sector

    Healthcare


Fundamentals

Shape

37.33x

P/E Ratio

6.32x

P/S Ratio

85.88x

P/B Ratio

0.7

Debt/Equity

18.7%

Net Margin

$13.4

EPS

How MEDP compares to sector?

P/E Ratio

Relative Strength

Shape

MEDP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape337%

2026-Revenue

$15.64

Shape395%

2026-EPS

$537M

Shape356%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(N/A)

Number of analyst

0

Last analyst upgrade/downgrade

Cowen & Co.

downgrade

Previous: Buy

2025-07-23

Now: Sell

Barclays

initialise

Previous: Outperform

2025-06-24

Now: Cautious

William Blair

downgrade

Previous: Not converted

2025-04-22

Now: Market Perform

UBS

downgrade

Previous: Buy

2024-09-27

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.23

arrow
arrow

+8%

2.22
vs 2.05

Q4.23

arrow
arrow

+16%

2.46
vs 2.12

Q1.24

arrow
arrow

+41%

3.2
vs 2.27

Q2.24

arrow
arrow

+42%

2.75
vs 1.93

Q3.24

arrow
arrow

+36%

3.01
vs 2.22

Q4.24

arrow
arrow

+49%

3.67
vs 2.46

Q1.25

arrow
arrow

+15%

3.67
vs 3.2

Q2.25

arrow
arrow

+13%

3.1
vs 2.75

Q3.25

arrow
arrow

+17%

3.52
vs 3.01

Q4.25

arrow
arrow

+2%

3.75
vs 3.67

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.23

arrow
arrow

+28%

492.5M  vs 383.7M

Q4.23

arrow
arrow

+26%

498.4M  vs 394.1M

Q1.24

arrow
arrow

+18%

511M  vs 434.1M

Q2.24

arrow
arrow

+15%

528.1M  vs 460.9M

Q3.24

arrow
arrow

+8%

533.3M  vs 492.5M

Q4.24

arrow
arrow

+8%

536.6M  vs 498.4M

Q1.25

arrow
arrow

+9%

558.6M  vs 511M

Q2.25

arrow
arrow

+14%

603.3M  vs 528.1M

Q3.25

arrow
arrow

+18%

629.3M  vs 533.3M

Q4.25

arrow
arrow

+20%

645.6M  vs 536.6M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+21%

0.21
vs 0.18

Q2.23

arrow
arrow

+16%

0.16
vs 0.21

Q3.23

arrow
arrow

+15%

0.15
vs 0.16

Q4.23

arrow
arrow

+14%

0.14
vs 0.15

Q1.24

arrow
arrow

+15%

0.15
vs 0.14

Q2.24

arrow
arrow

+12%

0.12
vs 0.15

Q3.24

arrow
arrow

+11%

0.11
vs 0.12

Q4.24

arrow
arrow

+14%

0.14
vs 0.11

Q1.25

arrow
arrow

+19%

0.19
vs 0.14

Q2.25

arrow
arrow

+52%

0.52
vs 0.19

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

425

425
vs 434

-2%

Q2.23

arrow
arrow

466

466
vs 425

10%

Q3.23

arrow
arrow

497

497
vs 466

7%

Q4.23

arrow
arrow

555

555
vs 497

12%

Q1.24

arrow
arrow

611

611
vs 555

10%

Q2.24

arrow
arrow

634

634
vs 611

4%

Q3.24

arrow
arrow

593

593
vs 634

-6%

Q4.24

arrow
arrow

593

593
vs 593

NA

Q1.25

arrow
arrow

585

585
vs 593

-1%

Q2.25

arrow
arrow

603

603
vs 585

3%

Earnings Growth

Latest News